dr. conway would mention them so i won't . then there's also nine pioneer models which are required to take on financial risk. i say that about a quarter of the mssp's i just mentioned shared in savings as results came out for 2014 about half of the pioneers were able to share in savings, and that model did get certified to be expanded. then the last little model i want to note is the bundled payments model. i would just characterize this model on one that focuses on a whole episode of care rather than payments made to individual providers for individual services that they themselves provide. the bpci demo has four different payment models that are triggered by a hospitalization but there are many details so i'm not really going to get into them, but to say that the results are very preliminary. so finally, i will just close with a few comments on ongoing challenges and opportunities. we see here that -- actually i have to put my glasses on. cms has launched -- to be fair a large number of payment models in a very short period

dr. conway? i see the person that is eyed for doing the work says you can make the 120 days. >> that is correct. >> my final question, go to recognize the ranking member for his closing remarks. mr. tillotson, let me share a concern that i have. we want to always give our fighting men and women the resources that they need. and yet what i heard today was a less than robust implementation of some of the gao reports as it relates to your particular area. i also heard you saying we are making progress and all the. what i don't want to do is see that 40% of what you would that really has no impact come substantial impact in terms of a bottom line to intimate it year after year and the 60% that would actually make very systemic changes continue to get rolled over. that's what i'm seeing. that's what i'm reading. is that we are making limited progress as it relates to that. and what happens is that makes t very difficult on someone who is trying to make those appropriation decisions on giving you the t

dr. conway, too. maybe anybody else want to join in, that would be terrific. everyone including presidential candidates is talking lately about the problem of rising drug costs. how will these demos address the problem and are there any particular demos that directly address this issue? i think i know from where you were speaking this morning that you have a specific demonstration to talk about. >> yes. so a number of the models before i talk about the specific one do include drug costs, typically b costs, but next generation even includes the possibility of organizations bringing in d costs. our own care model which we had robust interest in, we look forward to announcing the participants, also includes both a and b costs so includes drugs. we do have a part b model which i spoke this morning about that directly focuses on paying for value and better patient outcomes in part b. i want to say clearly it does not limit access. we do not believe the proposal limits access for any patient to get any drug they need and any physician to describe any drug they think

dr. conway? i see the person that is doing the work said you could make the 120 days. that is correct. all right. thank you. and my final question, then i'm going to recognize the ranking member for his closing remarks, mr. till itson, let me share a concern that i have. we have -- we want to always give our fighting men and women the resources that they need. and yet what i heard today was a less than robust implementation of some of the gao reports as it relates to your particular area. i also heard you saying, well we're making progress and all of that. what i don't want to do is see that 40% of what you implement, really have no impact -- substantial impact in terms of the bottom line getting implemented year and year and the 60% that would actually make very systemic changes continue to get rolled over. and that is what i'm seeing. that is what i'm reading. is that we're making limited progress as it relates to that. and what happens is, it makes it very difficult on someone who is trying to make those appropriation decisions on giving you the tools that you need and yet we hear a

dr. conway? i see the person that is actually doing the work said you can make the 120 days. >> that is correct. >> thank you. and my final question, then, i'm going to recognize the ranking member for his closing remarks, mr. till lot son, let me share a concern that i have. we have -- we want to always give our fighting men and women the resources that they need and yet what i heard today was a less than robust implementation of some of the gao reports as it relates to your particular area. i also heard you saying, well, we're making progress and all of that. what i don't want to do is see that 40% of what you implement that really have no impact, substantial impact, in terms of the bottom line get implemented year after year and the 60% that actually would make very systemic changes continue to get rolled over and that's what i'm seeing. that's what i'm reading is that we're making limited progress as it relates to that. and what happens is it makes it very difficult on someone who is trying t

dr. patrick conway. doctor, you've got -- you've got a title here. acting principle director -- acting principal deputy administrator, deputy chief administrator for innovation equality and chief medical officer at centers for medicare and medicaid services at the united states department of health and human services. so, i thank you, again, for all of your good work and being here. pursuant to committee rules, all witnesses are to be sworn before they testify. those on the panel as well as those that accompanied mr mr. dodaro, if you would all rise and raise your right hand.

dr. conway. thank each of you for your testimony. i'm going to recognize the gentleman from tennessee for a series of questions. but before i do that, i think it's important as we look at this particular issue and duplicative services and recognize one of the best assets the federal government has and that's its employees. it's easy to start looking at on inefficiencies and problems and undermine really our federal workforce, so i wanted to go on record to say, a thank you to the 99.5% of the federal workforce that does an outstanding job each and every day. and sometimes we focus on that 0.5% and paint a very broad brush. i don't want this hearing to do that as we really look at meaningful ways to make sure that we have a cost safings. with that i would recognize the gentleman from tennessee, my good friend, mr. duncan, for five minutes. >> well, thank you very much, mr. chairman. thank you and chairman chaffetz for calling this hearing, an annual hearing that i think is one of the most important hearings we hold each year. mr. doda

dr. conway? i see the person that actually is doing the work who says you can make the 120 days. thank you. and my final question then i'm going to recognize the ranking member for his closing remarks, mr. tillotson, let me share a concern i have that. we have -- we want to always give our fighting men and women the resources that they need yet what i heard today was a less-than-robust implementation of some of the gao reports as it relates to your particular area. i also heard you saying well, we're making progress on all of that ch that. what i don't want to do is see that 40% of what you implement that really have no pam pact, substantial impact on terms of the bottom line get impacted year after year and the 60% that would make very systemic changings get rolled over. that's what i'm seeing, that's what i'm reading is that we're making limited progress as it relates to that and with what happens is it makes it very difficult on someone who is trying to make those appropriations decisions on giving you the tools that you need and yet we hear about gross inefficiencies so it's

dr. patrick conway. you've got a title here. acting principal deputy administrator, deputy chief administrator for innovation equality and chief medical officer at the centers for medicare and medicaid services at the united states department of health and human services. i thank you again for your good work and for being here. pursuant to committee rules all witnesses are to be sworn before they testify. those on the panels and those that accompany, if you rise and raise your right hand. do you swear or affirm the testimony you are about to give will be the truth, the whole truth and nothing but the truth? thank you. you may be seated. let the record reflect all witnesses answered in the affirmative. we would ask the four panelists here at the table to please limit your oral testimony to five minutes and members should have ample time to answer questions. mr. dadaro, your discretion if you want to yield time to a particular individual as we get into the questions. we have a seat there if need be. mr. dadaro, you are recognized

dr. conway. thank each of you for your testimony. i'm going to recognize the gentleman from tennessee for a series of questions but before i do that i think it's important as a look at this particular issue and duplicative services in deficiencies, to recognize one of the greatest assets the federal government has come and that's its federal employees. in doing that it's very easy to start looking at the inefficiencies and the problems, and undermine really our federal work force. i want to go on record to say thank you to the 99.5% of the federal workforce that does an outstanding job each and every day, and sometimes we focus on the .5% and paint a broad brush. i don't want this hearing to do that as we were look at meaningful ways to make sure that we have cost savings. without i would recognize the gentleman from tennessee, my good friend mr. duncan, for five minutes. >> thank you. thank you, mr. chairman. thank you and chairman chaffetz for calling this hearing, nanuet i think is one of the most important hearings that we hold e

dr. patrick conway. you've got a title here. acting principal deputy administrator, deputy chief administrator for innovation equality and chief medical officer at the centers for medicare and medicaid services at the united states department of health and human services. i thank you again for your good work and for being here. pursuant committee rules all witnesses are to be sworn before they testify. those on the panels and those that accompany, if you rise and raise your right hand. do you swear or affirm the testimony you are about to give will be the truth, the whole truth and nothing but the truth? thank you. you may be seated. let the record reflect all witnesses answered in the affirmative. we would ask the four panelists here at the table to please limit your oral testimony to five minutes and members should have ample time to answer questions. mr. dadaro, your discretion if you want to yield time to a particular individual as we get into the questions. we have a seat there if need be. mr. dadaro, you are recognized for